Arrowstreet Capital’s Chimerix, Inc. CMRX Stock Holding History

Arrowstreet Capital’s Portfolio CMRX Stock Details CMRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-123,376	Closed	-$382K	–	2562
2020 Q2	$382K	Buy	+123,376	New	+$319K	﹤0.01%	2035
2015 Q2	–	Sell	-12,900	Closed	-$486K	–	1316
2015 Q1	$486K	Buy	+12,900	New	+$512K	﹤0.01%	843

Other funds holding CMRX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

NLVP

New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Arrowstreet Capital's CMRX Position: Q3 2020 in Review

Arrowstreet Capital sold out of Chimerix, Inc. (CMRX) in Q3 2020, closing a stake of 123,376 shares — an estimated $382K sold.

Arrowstreet Capital first reported a position in CMRX in Q1 2015 and held it in 2 quarters. The position peaked at $486K in Q1 2015. 79 funds tracked by Wall St. Rank hold CMRX as of Q3 2020.

Arrowstreet Capital reported no remaining Chimerix, Inc. position as of Q3 2020 after selling out during the quarter.
Arrowstreet Capital sold 123,376 Chimerix, Inc. shares in Q3 2020, an estimated $382K.
Arrowstreet Capital first reported a position in Chimerix, Inc. in Q1 2015 and held it in 2 quarters.
Arrowstreet Capital's Chimerix, Inc. position peaked at $486K in Q1 2015.
79 funds tracked by Wall St. Rank held Chimerix, Inc. as of Q3 2020.

Based on Arrowstreet Capital's 13F filing for Q3 2020, filed 12 Nov 2020.